Patient P-03306

Synthetic patientONX-7 · Day 145 · 35–44 · M · baseline S02Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

28%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 ONX-7 started — Baseline state S02
Day 14 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 18 HY-01 recommended — Hydration Protocol HY-01
Day 19 Patient accepted — Started HY-01 in the companion
Day 23 No meaningful change — Hydration Protocol HY-01

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days

Treatment adherence-13
Nutritional resilience-7
GI instability+5
Toxicity+5

What helped?

Hydration Protocol HY-01Day 18
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level

Daily log

4.7/10

stable · -0.1 vs previous 14 d

Stress level

Daily log

4.4/10

worsening · +0.3 vs previous 14 d

Pessimism score

Daily log

4.4/10

stable · -0.1 vs previous 14 d

Sleep quality

Wearable

36.4/100

stable · -0.1 vs previous 14 d

Libido

Daily log

4.4/10

worsening · -0.5 vs previous 14 d

HRV

Wearable

48.4 ms

stable · -1.5 vs previous 14 d

Toxicity

Blood

30.4/100

worsening · +10.9 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 69 from the failing basin, 22 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -2.8 next day on high-intake days · n 20

Would not help

HY-01 Hydration Protocol
already tried, no meaningful change
AD-05 Adherence Support
only 27% improved among 15 similar
Keep fat low
GI +2.2 next day on high-intake days · n 17

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-2.8supporter · 95%
Dietary fat load
+2.2detractor · 95%
Alcohol
+0.9no signal · 34%
Lactose
+0.6no signal · 17%
Histamine load
-0.2no signal · 15%
Caffeine
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓60
- MicrobiomeButyrate capacity 29/100
- MicrobiomeF. prausnitzii depleted
Autonomic recovery ↓20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 2.6 · butyrate capacity 29/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 51 ms
Sleep: 5.9 h
Steps: 8,213
Resting HR: 72 bpm

Daily log: GI score 19, nutritional resilience 66, adherence 79.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-03111	40%	S07	AD-05	no change	48
P-03204	40%	S16	AD-05	improved	48
P-03105	39%	S12	AD-05	no change	60
P-03424	36%	S12	AD-05	improved	41
P-03351	34%	S07	AD-05	no change	51
P-03482	34%	S05	AD-05	no change	67
P-03158	33%	S17	AD-05	no change	37
P-03369	33%	S18	AD-05	no change	37
P-03380	33%	S16	AD-05	improved	34
P-03034	32%	S14	AD-05	no change	30
P-03122	32%	S13	AD-05	no change	40
P-03129	30%	S18	AD-05	no change	32